Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Targeting mutated KRAS in the first‐line therapy
Targeting mutated KRAS in the first‐line therapy
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Author:
Hideaki Ijichi
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Clinical and Translational Discovery
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/ctd2.291
Similar Items
Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
by: Xinni Chen, et al.
Published: (2026)
Invited letter MUC4 mutations as an amplifier of complement‐mediated thrombosis in paroxysmal nocturnal haemoglobinuria
by: Eng Soo Yap, et al.
Published: (2026)
Challenges and advances of immune checkpoint therapy
by: Lingyu Li, et al.
Published: (2024)
Drug Sensitivity patterns across FAB subtypes and molecular mutations in AML: A comprehensive analysis for precision medicine
by: Mobina Shrestha, et al.
Published: (2025)
Milk exosomes: Harnessing nature's duality for cancer therapy
by: Asmit Das, et al.
Published: (2024)